Background {#Sec1}
==========

*Enterobacteriaceae*, such as *E.coli*, *K. pneumoniae* and *C. freundii*, are important pathogens that cause human infections. Carbapenem antibiotics are used in the treatment of infections caused by multi-drug resistant *Enterobacteriaceae*. However, the emergence of Carbapenem-resistant *Enterobacteriaceae* (CRE) has been a serious challenge to manage in the clinic because of the rapid worldwide dissemination of multi-drug resistance \[[@CR1]\]. As one main type of carbapenemases, New Delhi metallo-β-lactamase (NDM)is able to confer resistance to almost all β-lactams, including carbapenems, in *Enterobacteriaceae*. Since the first report of *bla*~NDM-1~, 17 variants of NDM enzymes (NDM-1 to NDM-17) have been identified among Gram-negative bacteria worldwide ([http://www.ncbi.nlm.nih.gov/pathogens/submit_beta_lactamase/](http://www.ncbi.nlm.nih.gov/pathogens/submit_beta_lactamase)). Among NDM carbapenemases, New Delhi metallo-β-lactamase-5, first identified in an *E. coli* strain in the UK in 2011, attracted extensive attention because of increased resistance to carbapenems and broad-spectrum cephalosporins \[[@CR2]\]. In addition, *bla*~NDM-5~ was reported to be carried in different incompatibility typing plasmids to transfer \[[@CR3]\], such as IncF, IncN and IncX3. These plasmids are able to facilitate the dissemination of *bla*~NDM-5~ among the members of *Enterobacteriaceae* through horizontal gene transfer. NDM-5-producing isolates have been identified worldwide, such as in America \[[@CR4]\], Australia \[[@CR5]\], China \[[@CR6]\], Denmark \[[@CR7]\] and India \[[@CR8]\]. Furthermore, NDM-5-positive strains were not only isolated from clinical specimens but also from animals, such as dogs \[[@CR9]\], cats \[[@CR10]\] and cows \[[@CR11]\]. Worryingly, *bla*~NDM-5~ has also been identified in environmental samples \[hospital sewage water \[[@CR12]\] and urban river \[[@CR13]\]\], indicating its presence in the community. However, the dissemination mechanism of *bla*~NDM-5~ gene remains unclear.

In this study, we screened NDM-5-producing *Enterobacteriaceae* to elucidate the dissemination mechanism. In addition, to the best of our knowledge, this report is the first to isolate *E. coli* and *C. freundii* strains carrying *bla*~NDM-5~ from the same patient.

Methods {#Sec2}
=======

Bacterial strains {#Sec3}
-----------------

From Jun. 2016 to Sep. 2017, 224 carbapenem-resistant *Enterobacteriaceae* isolates, as determined by the agar dilution method according to the Clinical and Laboratory Standards Institute guidelines \[[@CR14]\], were obtained from four hospitals in different locations in Zhejiang, China. In a retrospective study, common carbapenemase genes (*bla*~KPC~, *bla*~IMP~, *bla*~VIM~, *bla*~OXA-48~, and *bla*~NDM~) were amplified, and the positive products were sequenced; eleven NDM-5 producing strains were identified for further study. The NDM-5 producing strains were preliminarily identified by the VITEK 2 system (Sysmex-bioMérieux, Marcy l'Etoile, France) and further confirmed by whole genome sequencing. The characteristics of the isolates and related clinical data are shown in Table [1](#Tab1){ref-type="table"}.Table 1Clinical characteristicsIsolatesDate of hospitalizationDate of isolationPatient SexPatient Age (years)Clinical SampleHospital WardClinical DiagnosisAntimicrobial TherapyOutcomeEC1352016/5/272016/6/20Male85SputumICUAcute renal failureCPS, LEVDeathKP3872017/6/72017/6/26Male40bloodHematologyMyelodysplastic syndromesTGC, LEV, AMKAliveEC1262016/7/292016/8/10Female76urineSurgeryUracratiaCPS, TGCAliveEC7342016/7/272016/9/9Female61pusICUKidney neoplasmsCPS, IMP, LEV, TGCDeathEC4632016/10/72016/10/24Male16bloodHematologyAcute lymphoblastic leukemiaAMK, IMP, TZPAliveEC1442016/10/242016/11/3Female50ascitesSurgeryGastric cancerCPS, AMKAliveEC1222017/5/52017/5/23Male69urineICUAspiration pneumoniaTZP, CPS, LEVAliveEC6112017/6/122017/7/5Male72ascitesSurgeryColonic neoplasmsTZP, CPS, IMPAliveEC4182017/7/112017/7/22Female27fecesHematologyAcute myelogenous leukemiaIMP, MEM, LEVAliveCF4182017/7/112017/7/22Female27fecesHematologyAcute myelogenous leukemiaIMP, MEM, LEVAliveEC3102017/6/202017/7/29Female55bloodInfectious DiseaseBiliary tract infectionCPS, IMP, LEV, ATM, AMK, TGCAlive*MNO* minocycline, *MEM* meropenem, *LEV* levofloxacin, *TZP* piperacillin/tazobactam, *CPS* cefperazone/sulbactam, *TGC* tigecycline, *IMP* imipenem, *AMK* amikacin

Antimicrobial susceptibility testing {#Sec4}
------------------------------------

Antimicrobial susceptibility testing was performed using broth microdilution method \[[@CR14]\]. The antibiotics tested in this study were amikacin, aztreonam, cefepime, ceftazidime, ciprofloxacin, gentamicin, imipenem, minocycline, colistin and tigecycline. The results were analysed according to the CLSI guidelines \[[@CR14]\], except tigecycline and colistin, for which the European Committee on Antimicrobial Susceptibility Testing breakpoints were used (<http://www.eucast.org/clinical_breakpoints>). *E. coli* ATCC 25922 was used as a quality control strain.

Bacterial genotyping {#Sec5}
--------------------

Pulsed-field gel electrophoresis (PFGE) was performed to analyse the clonal relatedness of the NDM-5 producing *E. coli* isolates according to the previous study \[[@CR15]\]. Briefly, the isolates were digested by *X*baI endonuclease, which was carried out with a CHEF-Mapper XA PFGE system (Bio-Rad, USA) with a 5--35 s linear ramp for 22 h at 6 V/cm and 14 °C. The PFGE profiles were analyzed with BioNumerics software (Applied Maths, Sint-Martens-Latern, Belgium). The *Salmonella enterica* serotype Braenderup H9812 was used as the size marker.

MLST was also performed for molecular typing. Bacterial genomic DNA was extracted from these isolates. Seven housekeeping genes of *E. coli* (*adk*, *fumC*, *gyrB*, *icd*, *mdh*, *purA* and *recA*), and *K. pneumoniae* (*gapa*, *infb*, *mdh*, *pgi*, *phoe*, *rpob*) were amplified by PCR, and the products were sequenced to analyse the ST.

Southern blot analysis and conjugation experiments {#Sec6}
--------------------------------------------------

To determine the plasmid location of the *bla*~NDM-5~ gene, genomic DNA digested with S1-nuclease (TaKaRa, Japan) was electrophoresed on a CHEF-mapper XA pulsed-field gel electrophoresis (PFGE) system (Bio-Rad, USA) for 18 h at 14 °C with run conditions of 6 V/cm and pulse times from 2.16 s to 63.8 s. The DNA fragments were transferred to a positive-charged nylon membrane (Millipore, USA) and then hybridized with a digoxigenin-labeled *NDM-5*-specific probe. An NBT/BCIP color detection kit (Roche, Germany) was then used to detect the fragments. The *Salmonella enterica* serotype Braenderup H9812 was used as the size marker.

A filter-mating experiment was performed between the *bla*~NDM-5~-positive isolates and rifampicin-resistant *E. coli* C600 as the recipient strain \[[@CR15]\]. Transconjugants were selected on Mueller-Hinton agar plates containing 500 mg/L rifampicin and 100 mg/L ampicillin. PCR sequencing and antimicrobial susceptibility testing of the transconjugants were subsequently carried out to confirm whether the plasmid was successfully transferred to the recipient.

Plasmids analysis {#Sec7}
-----------------

Plasmid extraction and analysis was performed as previously described \[[@CR15]\]. Briefly, the plasmid DNA of strains was extracted using a QIAamp DNA MiniKit (Qiagen, Valencia, CA, USA) following the manufacturer's recommendations. The plasmids were sequenced on an Illumina-Hiseq™ 2000 (Illumina Inc., San Diego, U.S.A) platform with 2 × 100 bp paired-end reads. Sequence reads were assembled using CLC Genomics Workbench software package (CLC Bio 8.0). Gaps of a representative plasmid were closed by standard PCR and Sanger sequencing according to previous study \[[@CR16]\]. The RAST (Rapid Annotation using Subsystems Technology) annotation website server (<http://rast.nmpdr.org/rast.cgi>) was then used to annotate the genomes of the plasmid. The circular map of the pEC463-NDM5 plasmid was generated using the CGview server \[[@CR17]\]. A comparison of pEC463-NDM5 and three related plasmids was performed with EasyFig 2.2.2 \[[@CR18]\]. The rested plasmid sequences were mapped to the representative plasmid sequence with CLC genomics workbench version 8.0.

Incompatibility typing of the *bla*~NDM~ plasmid was performed by PCR-based replicon typing \[[@CR19], [@CR20]\] and was further identified with the help of PlasmidFinder-1.3 server ([https://cge.cbs.dtu.dk/services/PlasmidFinder/](https://cge.cbs.dtu.dk/services/PlasmidFinder)).

In addition, plasmid stability was determined \[[@CR3]\]. Briefly, the *bla*~NDM-5~-positive isolates were individually streaked out in the MH agar, incubated at 37 °C for 24 h, and then transferred to a fresh MH agar. After repeating this procedure for 12 days, 12 individual colonies were randomly selected. Subsequently, the *bla*~NDM-5~ gene was screened by PCR and sequenced.

Nucleotide sequence accession number {#Sec8}
------------------------------------

The complete sequence of the plasmid pEC463-NDM5 (accession number MG545911), is deposited at DDBJ/EMBL/GenBank.

Results and discussion {#Sec9}
======================

Isolate characteristics and antimicrobial susceptibility testing {#Sec10}
----------------------------------------------------------------

Among the 224 CRE isolates, 137 isolates were KPC-2 carbapenemase producers, eleven isolates were NDM-5 carbapenemase producers, four isolates carried *bla*~IMP-1~ gene, two isolates carried *bla*~VIM-1~ gene and two isolates carried *bla*~NDM-1~ gene. In addition, 68 isolates exited other unknown mechanism of carbapenem-resistance.

In this study, eleven NDM-5-producing isolates were further identified, including nine *E. coli*, one *K. pneumoniae* and one *C. freundii*. These isolates were all recovered from hospitalized patients. These patients were aged between 16 and 85 years, with an average age of 55 years, had different severities of illness (Table [1](#Tab1){ref-type="table"}), and all had previously received broad-spectrum antibiotics. Notably, with both *E. coli* (EC418) and *C. freundii* strains (CF418) were isolated from the feces of one patient from haematology department. This patient was found to be a carrier of *bla*~NDM-5~-positive strains. In contrast, the other patients from whom *bla*~NDM-5~-carrying strains were isolated from blood, pus, ascites, urine or sputum were symptomatic. In addition, these patients had no recent history of travel or hospitalization abroad.

The antimicrobial susceptibility testing results showed that the *bla*~NDM-5~-positive isolates were resistant to carbapenems, third-generation cephalosporins, and cefperazone/sulbactam. These isolates were also resistant to fluoroquinolones (81.8%), aztreonam (36.4%), amikacin (36.4%), nitrofurantoin (45.4%) and tigecycline (18.2%). All isolates were susceptible to colistin. *E.coli* EC122 and *K. pneumoniae* KP387 strains were both resistant to tigecycline, suggesting that increased resistance phenotypes of *bla*~NDM-5~-postive isolates are increasing in clinics. In addition, other β-lactamase genes, such as those encoding CTX-M-24, CTX-M-55, CMY-42, were also frequently detected in various *bla*~NDM-5~-positive *E. coli* strains (Fig. [1](#Fig1){ref-type="fig"}). Gene encoding SHV-1 and CMY-26 were detected in the *K. pneumoniae* KP387 and *C. freundii* CF418 strains, respectively.Fig. 1The dendrogram is based on the similarity of PFGE patterns from 9 *bla*NDM-5 positive clinical *E. coli* isolates. The right illustrates results from MLST, hospitals and β-lactamase gene(s)Fig. 2S1-digested plasmid DNA and southern blot hybridization of *bla*NDM-5 positive isolates. Bands in A with arrows pointing to them showed positive signals in Southern blot hybridization with the NDM-5 probe. M = *Salmonella serotype Braenderup* strain H9812 molecular marker. 1 = *K. pneumoniae* KP387; 2 = *E. coli* EC135; 3 = *E. coli* EC463; 4 = *E. coli* EC734; 5 = *E. coli* EC144; 6 = *E. coli* EC122; 7 = *E. coli* EC418; 8 = *C. freundii* CF418; 9 = *E. coli* EC310; 10 = *E. coli* EC611; 11 = *E. coli* EC126

Our recent studies showed that *bla*~NDM-5~ was able to coexist in the same isolate with tigecycline and colistin resistance phenotypes, thereby generating strains that approached pan-resistance. For example, *bla*~NDM-5~ was not only identified in high-level tigecycline resistance *E. coli* strains \[[@CR21]\], but also coexisted in the same strain with the transferrable colistin resistance gene *mcr-1* \[[@CR15]\]. It is clear that generating strains results in so-called "superbug" isolates and accelerating entery into a "postantibiotic" era \[[@CR22]\].

Genetic relatedness {#Sec11}
-------------------

MLST and PFGE experiments were performed to analyse the clonal relatedness of *bla*~NDM-5~-positive isolates because NDM-5 producers are infrequently isolated worldwide. According to the MLST results, nine *bla*~NDM-5~-postive *E. coli* isolates were grouped into 9 different sequence types. In accordance with the MLST results (Fig. [1](#Fig1){ref-type="fig"}), the different PFGE patterns confirmed that the seven *E. coli* isolates are not clonally related to each other even though some of the strains were collected from the same hospital. Strains EC122 and EC144 own similar the PFGE profiles, but the two strains have different sequence type and different resistance genes. Furthermore, core genome multi-locus sequence typing (cg-MLST) analysis in our study showed the *bla*~NDM-5~-positive isolates were not clonal relatedness (Additional file [1](#MOESM1){ref-type="media"}: Figure S1). In addition, the *K. pneumoniae* KP487 isolate belongs to ST182.

A previous study collected 11 NDM-5-producing *E. coli* strains from 7 hospitals in various locations in China from 2013 to 2014, and found that ST16*7 E. coli* strains in clinical settings exhibited close linkages with the *bla*~NDM-5~ gene \[[@CR23]\]. Our previous study also showed that high-level tigecycline resistance *E. coli* strains carrying *bla*~NDM-5~ also belonged to the ST167 clonal lineage \[[@CR21]\], indicating that the ST167 sequence type is an important reservoir of *bla*~NDM-5~ in China. However, the diversity of MLST and PFGE types in the present study showed that the *bla*~NDM-5~ gene has been carried in other STs *E. coli* isolates from 2016 to 2017. Moreover, the *bla*~NDM-5~ gene was detected in the *K. pneumoniae* and one *C. freundii* strains, indicating that this gene has further disseminated in *Enterobacteriaceae*. Note that NDM-5-related outbreak has been reported \[[@CR24], [@CR25]\]. Although no genetic association was found between our *bla*~NDM-5~-positive isolates with other strains, the widespread dissemination of *bla*~NDM-5~ in recent years in *Enterobacteriaceae* highlights the need for extensive attention.

Location of the *bla*~NDM-5~ gene {#Sec12}
---------------------------------

S1-PFGE followed by Southern blot demonstrated that the *bla*~NDM-5~-positive strains were all located on plasmids of the same size(\~ 46 Kb) (Fig. [2](#Fig2){ref-type="fig"}). The filter mating experiments were carried out to confirm the transferability of these *bla*~NDM-5~ plasmids. Nine of the 11 isolates tested could successfully transfer their carbapenem-resistant phenotype to *E. coli* strain C600 (Table [2](#Tab2){ref-type="table"}). In addition,incompatibility plasmid classification showed that all the *bla*~NDM-5~ plasmids belonged to the IncX3-type plasmid. IncX3 plasmids might have played an important role in mediating the horizontal transmission of the *bla*~NDM~ gene. This possibility has been supported by the results of several studies \[[@CR6], [@CR26]--[@CR29]\]. In this study, *bla*~NDM-5~ was carried by the IncX3 plasmids. Moreover, 81.8% (9/11) of isolates carrying this type plasmid were able to transfer carbapenem-resistant phenotype. However, conjugation experiments of *E. coli* EC126 and EC135 strains were not performed because these two strains were resistant to rifampin. To date, IncX3 plasmids carrying *bla*~NDM-5~ have been reported worldwide \[[@CR3], [@CR22], [@CR23]\]. Therefore, our present study further supplements those previous studies. In addition, we isolated *E. coli* and *C. freundii* strains carrying *bla*~NDM-5~ from a single patient. These *bla*~NDM-5~-carrying plasmids had very similar sequences (99% coverage and 98% similarity), indicating probable horizontal transfer of *bla*~NDM-5~ between *E. coli* and *C. freundii* strains by one same plasmid. In addition, the plasmid stability experiments showed that the *bla*~NDM-5~-positive plasmids were all stable in these isolates. After 12 rounds of subculture in MH agar without antibiotic addition, the randomly selected strains all carried the *bla*~NDM-5~ gene and a plasmid identical to their parental isolate in size. Overall, it is important for the IncX3 type plasmid to play an important role in the further dissemination of *bla*~NDM-5~ in *Enterobacteriaceae.* Therefore, it is imperative that effective measures be taken immediately to control the spread of this plasmid.Table 2Antibiotic susceptibility of NMD5-producing isolates and their transconjugantsIsolatesMICs (mg/L)FEPIPMNITCAZAMKCIPATMTGCCPS2/1MNOCOLEC126\> 1288128\> 128\> 128128\> 1280.5\> 25680.5EC135641664\> 1281281280.1252\> 256320.5KP3876416128\> 128120.254\> 256320.5JH387641616\> 1280.50.50.250.5\> 25640.5EC463\> 128648\> 128164322\> 256640.5JH 4631286416\> 12810.1250.1250.25\> 2562\< 0.25EC7346488\> 12816440.25\> 256320.5JH734641616\> 1280.50.250.1250.5\> 2562\< 0.25EC6113288\> 12810.06250.06250.25\> 25620.25JH6116488\> 1280.50.06250.1250.5\> 25620.25EC1441283232\> 128\> 128641280.25\> 256320.5JH1441281632\> 1280.50.50.1250.5\> 2562\< 0.25EC122\> 1283264\> 128\> 12864\> 2568\> 2561280.5JH1221281616\> 1280.50.50.1250.5\> 2562\< 0.25EC41832832\> 12810.250.1251\> 256480.5JH41832816\> 1280.50.250.1250.5\> 2562\< 0.25CF41832328\> 12810.250.l250.5\> 25640.5JHF4181688\> 12810.250.1250.5\> 2562\< 0.25EC310\> 1281288\> 128180.190.5\> 25620.5JHE310\> 128648\> 1280.50.50.1250.5\> 2561\< 0.25EC6000.1250.580.250.50.1250.250.1250.51\< 0.25ATCC25922^a^0.1250.5\< 80.1250.50.1250.1250.1250.250.25\< 0.25*FEP* cefepime, *IMP* imipenem, *NIT* nitrofurantoin, *CAZ* ceftazidime, *AMK* amikacin, *CIP* ciprofloxacin, *ATM* aztreonam, *TGC* tigecycline, *MNO* minocycline, *CPS* cefperazone/sulbactam, *COL* colistinAll susceptibility tests were repeated at least three times according to CLSI method. The results of colistin susceptibility were interpreted according to EUCAST breakpoints^a^quality control strain

Plasmid sequence analysis of *bla*~NDM-5~ {#Sec13}
-----------------------------------------

The entire plasmid sequence was obtained to better characterize the *bla*~NDM-5~-positive plasmid. Sequence analysis showed that the plasmid was 46,145 bp in length (Fig. [3a](#Fig3){ref-type="fig"}). The *bla*~NDM-5~ gene was preceded by IS*3000*, IS*Aba125* and IS*5*, and followed by *ble*~MBL~, *trpF*, *dsbC*, IS*6* and IS*kox3*.No other antimicrobial resistance genes were detected in this plasmid.Fig. 3Plasmid analysis of pEC463-NDM5. Schematic map of plasmid p pEC463-NDM5 (**a**), comparative analysis of three *bla*NDM-5-carrying IncX3 plasmids (**b**). The putative open reading frames are shown as arrowheads orrods (less than 130 amino acids). The gene name is shown near the corresponding arrowhead or rod. The depthof shading is indicative of the percentage BLASTN match, as indicated on the bottom

Further sequence alignments based on BLAST revealed that the plasmid sequences showed almost identical nucleotide sequences with those of the previously reported IncX3 plasmids pNDM-MGR194 of *K. pneumoniae* MGR-K194 in India \[[@CR8]\]. The plasmid pNDM-MGR194 carrying *bla*~NDM-5~ was reported in 2015 in India, which was considered to play an important role in the dissemination of the *bla*~NDM-5~ gene because pNDM-MGR194-like plasmid was highly similar to those plasmids reported in China \[[@CR3]\], Australia \[[@CR5]\] and Denmark \[[@CR7]\]. In addition, most of the *bla*~NDM-5~-carrying plasmids reported in China belonged to the IncX3-type and were identical or near-identical to pNDM-MGR194-like plasmid (Table [3](#Tab3){ref-type="table"}). In this study, identification of the IncX3-type pNDM-MGR194-like plasmid in *E. coli* of different STs, *K. pneumoniae* and *C. freundii* strains indicated that this plasmid could mediate inter- and intra-species transfer of *bla*~NDM-5~. This possibility was further supported by our conjunction experimental data in vitro. Moreover, this plasmid carried in *E. coli* and *C. freundii* strains was isolated from faeces sample of a single patient at the same time, providing strong evidence that this plasmid could mediate *bla*~NDM-5~ dissemination in *Enterobacteriaceae*. Overall, our results revealed that IncX3-type pNDM-MGR194-like plasmids facilitate the rapid dissemination of *bla*~NDM-5~ among *Enterobacteriaceae* in China.Table 3Detailed information of the *bla*~NDM-5~-habouring plasmids reported in the NCBI databaseInc. groupTransferability^a^Size (kb)Host strainMLSTSampleCountryReferenceIncX3T46^b^*K. pneumoniae*--Human BloodIndia\[[@CR8]\]--46^b^*E. coli*ST1284Human GroinDenmark\[[@CR24]\]--46^b^*E. coli*ST648Human UrineIndia\[[@CR5]\]C46^b^*E. coli*ST167Human RectumChina\[[@CR6]\]C46^b^*E. coli*ST167Human UrineChina\[[@CR30]\]C46^b^*E. coli*ST167Human BloodChina\[[@CR30]\]C46^b^*E. coli*ST2608Human SwabChina\[[@CR30]\]C46^b^*E. coli*ST5131Human Vaginal secretionsChina\[[@CR30]\]T46^b^*E. coli*ST167Human sputumChina\[[@CR3]\]T46^b^*E. coli*ST167Human UrineChina\[[@CR3]\]T46^b^*E. coli*ST167Human BloodChina\[[@CR21]\]T46^b^*E. coli*ST167Human BloodChina\[[@CR15]\]T46^b^*E. coli*ST206Human stoolChina\[[@CR31]\]C46^b^*K. michiganensis*--Human stoolChina\[[@CR32]\]C46^b^*E. coli*ST446Cows fecalChina\[[@CR11]\]C46^b^*E. coli*ST2Cows fecalChina\[[@CR11]\]C46^b^*E. coli*ST3Cows fecalChina\[[@CR11]\]C46^b^*E. coli*ST354Human ascitesChinathis studyC46^b^*E. coli*ST746Human fecesChinathis studyC46^b^*E. coli*ST6395Human bloodChinathis studyC46^b^*E. coli*ST6335Human pusChinathis studyC46b*E. coli*ST12Human ascitesChinathis study--46^b^*E. coli*ST410Human sputumChinathis studyC46^b^*E. coli*ST361Human bloodChinathis studyC46^b^*E. coli*ST167Human urineChinathis study--46^b^*E. coli*ST617Human UrineChinathis studyC46^b^*K. pneumoniae*Human bloodChinathis studyC46^b^*C. freundii*--Human fecesChinathis studyIncF--\> 100*E. coli*ST648Human throatUK\[[@CR2]\]T\> 100*E. coli*--Human pusIndia\[[@CR33]\]T\> 100*E. coli*--Human pusIndia\[[@CR33]\]IncFIIT84.5*Salmonella enterica serovar Typhimurium*ST34Human fecalChina\[[@CR34]\]C110*E. coli*ST418Human stoolPoland\[[@CR35]\]C90*E. coli*ST418Human urineSpain\[[@CR36]\]IncNC110*E. coli*ST540Human fecesJapan\[[@CR37]\]UntypeableC48*K. pneumoniae*ST231Human urineSingapore\[[@CR38]\]^a^C: plasmid is able to transfer to *E. coli* recipients by conjugation; T: plasmid is able to transfer to *E. coli* recipients by transformation or electroporation^b^These plasmids are identical or near-identical to plasmid pNDM-MGR194

Conclusions {#Sec14}
===========

We report a near-term epidemiological study demonstrating the further dissemination of *Enterobacteriaceae* with the *bla*~NDM-5~ gene in China. Our work provides evidence that the IncX3-type plasmid played an important role in the dissemination of *bla*~NDM-5~ in *Enterobacteriaceae*. In addition, to the best of our knowledge, this report is the first to isolate *E. coli* and *C. freundii* strains carrying *bla*~NDM-5~ from a single patient. Close surveillance is urgently needed to monitor the further spread of NDM-5-producing isolates.
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